Self-mutilation in the Lesch-Nyhan syndrome: A corporal consciousness problem? - A new hypothesis

Medical Hypotheses

Volumn 50, Issue 1, 1998, Pages 43-47

  Pellicer, F ^a,c   Buendia Roldan I ^b   Pallares Trujillo, V C ^a  

^a Inst Mexicano de Psiquiatría

^b UNIVERSIDAD LA SALLE   (Mexico)

^c INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 1 RECEPTOR; HYPOXANTHINE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ARTICLE; AUTOMUTILATION; CONSCIOUSNESS; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; HUMAN; HYPOTHESIS; LESCH NYHAN SYNDROME; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SUPERSENSITIVITY;

EID: 0031964025     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90176-1     Document Type: Article

References (39)

1. Lesch M, Nyhan W L. A familial disorder of uric acid metabolism and central nervous system function. Am J Med 1964; 36: 561-570.
2. Beck C T. Jacobus de Voragine (1230-1288): first to describe a Lesch-Nyhan syndrome? Eur J Pediatr Surg 1992; 2: 355-356.
3. Tohyama J, Nanba E, Kousaku O. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line. Hum Genet 1994; 93: 175-181.
4. Boyd M, Lanyon G, Connor JM. Screening for molecular pathologies in Lesch-Nyhan syndrome. Hum Mutat 1993; 2: 127-130.
5. Mansfield E S, Blasband A, Kronick M N et al. Fluorescent approaches to diagnosis of Lesch-Nyhan syndrome and quantitative analysis of carrier status. Mol Cell Probes 1993; 7: 311-324.
6. Yukawa T, Akazawa H, Miyake Y, Takahashi Y, Nagao H, Takeda E. A Female patient with Lesch-Nyhan syndrome. Dev Med Child Neurol 1992; 34: 534-546.
7. Bogaert P van, Ceballos I, Desguerre I, Telvi L, Kamount P, Ponsot G. Lesch-Nyhan syndrome in a girl. J Inherit Metab Dis 1992; 15: 790-791.
8. Kelley W N, Wyngaarden J B. Clinical syndromes associated with hypoxanthine-guanine phosphoribosyltransferase deficiency. The Metabolic Inherent Disease, 5th edn. New York: J B Stanbury, 1983: 1115.
9. Lapunzina P, Fauze R, Magdalena C et al. Síndrome de Lesch-Nyhan: presentatión de un caso con relatión a las anormalidades bioquimicas. Rev Esp Neurol 1992; 7: 339-341.
10. Mateos-Antón F, Garcia-Puig J. Diagnóstico prenatal del síndrome de Lesch-Nyhan. Neurologia (Madrid) 1992; 7: 63-69.
11. Seegmiller J E, Rosenbloom F M, Kelly W N. Enzyme defect associated with a sexlinked human neurological disorder and excessive purine synthesis. Science. 1967; 155: 1682-1684.
12. Jinnah H A, Gage F H, Friedmann T. Animal models of Lesch-Nyhan syndrome. Brain Res Bull 1990; 25: 467-475.
13. Howell R P. Defects in metabolism of purines and pyrimidines. In: Behrman R E, Vaughan V C III, eds. Nelson Text-book of Pediatrics. Philadelphia: Saunders, 1987: 344-347.
14. Origuchi Y, Miyoshino S, Mishima K, Mine K. Quantitative histologic study of the sural nerve in Lesch-Nyhan syndrome. Pediatr Neurol 1990; 6: 353-355.
15. Babinski J. Contribution a I étude des troubles mentaux dans l'hemiplegic organic cérébrale (anosognosie). Rev Neurol (Paris) 1914; 1: 845-847.
16. Jinnah H A, Gage F H, Friedmann T J. Animal models of Lesch-Nyhan syndrome. Brain Res Bull 1990; 25: 467-475.
17. Goldstein M, Kuga S, Kusano N, Meller E, Dancis J, Schwarcz R. Dopamine agonist induced self-mutilative biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brainstem: possible pharmacological model for Lesch-Nyhan syndrome. Brain Res 1986; 367: 114-120.
18. Breese G R, Criswell H E, Duncan G E, Mueller R A. A dopamine deficiency model of Lesch-Nyhan disease in the neonatal 6-OHDA-lesioned rat. Brain Res Bull 1990; 25: 477-484.
19. Finger S, Heavens R P, Sirinathsinghji D J S, Kuenn M R, Dunnett S B. Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome. J Neurol Sci 1988; 86: 203-213.
20. Wu C L, Melton D W. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase deficient mice. Nature Genet 1993; 3: 235-240.
21. Sandik R. Cholinergic mechanisms in Gilles de la Tourette's syndrome. Int J Neurosci 1995: 81: 95-100.
22. Gedye A. Serotonin-GABA treatment is hypothesized for self-injury in Lesch-Nyhan syndrome. Med Hypotheses 1992; 38: 325-328.
23. Lloyd K G, Hornykiewicz O, Davidson L et al. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 1981; 19: 1106-1111.
24. Goldstein M, Kuga S. Dopamine agonist induced compulsive biting behaviour in monkeys: animal model for Lesch-Nyhan syndrome. Soc Neurosci Abs 1984; 10: 239.1.
25. Goldstein M., Anderson L T, Reuben R, Dancis J. Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation. Lancet 1985; 1: 338-339.
26. Casas-Bruge M, Almenar C, Grau IM, Hane J, Herrera-Marschitz M, Ungerstedt U. Dopaminergic receptors super-sensitivity in self-mutilatory behaviour of Lesch-Nyhan disease. Lancet 1985; 1: 991.
27. Bennett G J, Xie Y-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988; 33: 87-107.
28. Vaccarino A L, Melzack R. Analgesia produced by injection of lidocaine into the anterior cingulum bundle of the rat. Pain 1989; 39: 213-219.
29. Melzack R. Phantom limbs and the concept of neuromatrix. Trends Neurosci 1990; 13: 88-92.
30. Vaccarino A L, Melzack R. Temporal processes of formalin pain: differential role of the cingulum bundle, fornix pathway and medial bulboreticular formation. Pain 1992; 49: 257-271.
31. Saadé N E, Shbeir S A, Atweh S F, Jabbur S J. Chemical lession in the neostratium inhibits autotomy behaviour in rats. Soc Neurosci Abs 1994; 20: 644.11.
32. Pellicer F, López-Avila A. The electric stimulation of the cingulum bundle anticipates the onset of autotomy induced by the chronic inflammation in rat. Soc Neurosci Abs 1996; 22: 54.1.
33. Vincent S L, Khan Y, Benes F M. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse 1995; 19: 112-120.
34. Williams G V, Goldman-Rakic P S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995; 376: 572-575.
35. Yang C R, Seamans J K. Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J Neurosci 1996; 16: 1922-1935.
36. Robbins T W. The case for frontostriatal dysfunction in schizophrenia. Schizophr Bull 1990; 16: 391-402.
37. Ernest M, Zametkin A J, Matochik J A, Pascualvaca D, Jons PH, Hardy K. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Eng J Med 1996; 334: 1568-1572.
38. Mathews W S, Solan A, Barabas G. Cognitive functioning in Lesch Nyhan syndrome. Dev Med Child Neurol 1995; 37: 715-722.
39. Anderson L T, Ernst M, Davis S V. Cognitive abilities of patients with Lesch-Nyhan disease. J Autism Dev Disord 1992; 22: 189-203.